Search Results
10
Everything
Search Filters
Organization
Anika Therapeutics Inc.
Anika Reports Fourth Quarter and Full Year 2024 Financial Results
March 12, 2025 16:05 ET
|
Anika Therapeutics Inc.
Full Year 2024 results in line with guidance with Commercial Channel revenue up 17% Strong International OA Pain Management and greater than 40% sequential growth of Integrity™ Implant System...
Anika Completes Divestiture of Parcus Medical
March 07, 2025 06:00 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., March 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the Osteoarthritis Pain Management and Regenerative Solutions space focused on early...
Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025
February 26, 2025 08:00 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue...
Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference
February 25, 2025 08:00 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl...
Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference
December 23, 2024 16:01 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl...
Anika To Participate in December 2024 Investor Conferences
November 22, 2024 16:16 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that senior...
Anika Reports Third Quarter 2024 Financial Results
October 31, 2024 07:05 ET
|
Anika Therapeutics Inc.
Updating 2024 fiscal year guidance to reflect announced changes to business strategy, including the sale of Arthrosurface and planned divestiture of Parcus Medical, and U.S. OA Pain Management...
Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical
October 31, 2024 07:00 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced the...
Anika Announces Third Quarter 2024 Results Conference Call Date
October 17, 2024 16:01 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue...
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 04, 2024 16:01 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on October 1,...